2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monkawa, T. Articles by Shankland, S. J Search for Related Content PubMed PubMed Citation Articles by Monkawa, T. Articles by Shankland, S. J

The Hypertrophic Effect of Transforming Growth Factor- is Reduced in the Absence of Cyclin-Dependent Kinase-Inhibitors p21 and p27

Toshiaki Monkawa^*, Keiju Hiromura^*, Gunter Wolf and Stuart J Shankland^*

*Department of Medicine, Division of Nephrology, University of Washington, Seattle, Washington; and Department of Medicine, Division of Nephrology and Osteology, University of Hamburg, Germany.

Correspondence to: Dr. Stuart J. Shankland, Division of Nephrology, University of Washington Medical Center Box 356521, Seattle, WA 98195. Phone: 206-543-3792; Fax: 206-685-8661; E-mail: stuartjs{at}u.washington.edu

ABSTRACT. Transforming growth factor- (TGF-) has both antiproliferative and hypertrophic effects on mesangial cells (MC). However, it is not known if these processes are independent or if they share common signaling pathways. Proliferation and hypertrophy are regulated by specific cell-cycle regulatory proteins, where the cyclin-dependent kinase (CDK) inhibitors inhibit target cyclin-CDK complexes. This study examined whether the growth regulatory effects of TGF- were determined by the CDK inhibitors p21 and p27. Accordingly, cultured MC from wild type (+/+) and single and double null (-/-) p21 and p27 mice were grown in 5% serum in the presence or absence of TGF-1 (2 ng/ml). Proliferation ([³H]-thymidine incorporation, cell number, cell cycle) and hypertrophy ([³H]-leucine incorporation, total protein content, forward light scatter) were measured after 24 h, 48 h, and 96 h. TGF- inhibited proliferation in +/+ and p21/p27 double -/- MC to a similar extent. TGF- induced hypertrophy in +/+ MC (18.0% increase at 48 h), and to lesser extent in p21 -/- (12.8%) and p27 -/- MC (11.5%) measured by forward light scatter analysis. In p21/p27 double -/-, the hypertrophic effects of TGF- were significantly reduced (3.9% at 48 h). Similar results were obtained by measuring hypertrophy by total protein and [³H]-leucine incorporation. In conclusion, the CDK inhibitors p21 and p27 are not required for the antiproliferative effects of TGF-. However, the hypertrophic growth effects of TGF- are reduced in the absence of both p21 and p27. These data suggest that the regulation of the antiproliferative and hypertrophic effects of TGF- may be distinct processes.

This article has been cited by other articles:

				T. Okada, J. Wada, K. Hida, J. Eguchi, I. Hashimoto, M. Baba, A. Yasuhara, K. Shikata, and H. Makino Thiazolidinediones Ameliorate Diabetic Nephropathy via Cell Cycle-Dependent Mechanisms Diabetes, June 1, 2006; 55(6): 1666 - 1677. [Abstract] [Full Text] [PDF]

				J. Chen, J.-K. Chen, E. G. Neilson, and R. C. Harris Role of EGF Receptor Activation in Angiotensin II-Induced Renal Epithelial Cell Hypertrophy J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1615 - 1623. [Abstract] [Full Text] [PDF]

				M. Baba, J. Wada, J. Eguchi, I. Hashimoto, T. Okada, A. Yasuhara, K. Shikata, Y. S. Kanwar, and H. Makino Galectin-9 Inhibits Glomerular Hypertrophy in db/db Diabetic Mice via Cell-Cycle-Dependent Mechanisms J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3222 - 3234. [Abstract] [Full Text] [PDF]

				C.-F. Xia, G. Bledsoe, L. Chao, and J. Chao Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats Am J Physiol Renal Physiol, September 1, 2005; 289(3): F622 - F631. [Abstract] [Full Text] [PDF]

				R. Nasrallah and R. L. Hebert Prostacyclin signaling in the kidney: implications for health and disease Am J Physiol Renal Physiol, August 1, 2005; 289(2): F235 - F246. [Abstract] [Full Text] [PDF]

				J.-K. Chen, J. Chen, E. G. Neilson, and R. C. Harris Role of Mammalian Target of Rapamycin Signaling in Compensatory Renal Hypertrophy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1384 - 1391. [Abstract] [Full Text] [PDF]

				G. Wolf and U. O. Wenzel Angiotensin II and Cell Cycle Regulation Hypertension, April 1, 2004; 43(4): 693 - 698. [Abstract] [Full Text] [PDF]

				S. V. Griffin and S. J. Shankland Not Just an Inhibitor: A Role for p21 Beyond The Cell Cycle--"The Truth Is Rarely Pure and Never Simple" J. Am. Soc. Nephrol., March 1, 2004; 15(3): 825 - 826. [Full Text] [PDF]

				D. Mitchell, K. Rodgers, J. Hanly, B. McMahon, H. R. Brady, F. Martin, and C. Godson Lipoxins Inhibit Akt/PKB Activation and Cell Cycle Progression in Human Mesangial Cells Am. J. Pathol., March 1, 2004; 164(3): 937 - 946. [Abstract] [Full Text] [PDF]

				K. Sharma, L. Deelman, M. Madesh, B. Kurz, E. Ciccone, S. Siva, T. Hu, Y. Zhu, L. Wang, R. Henning, et al. Involvement of transforming growth factor-{beta} in regulation of calcium transients in diabetic vascular smooth muscle cells Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1258 - F1270. [Abstract] [Full Text]

				S. Taneda, K. L. Hudkins, S. Topouzis, D. G. Gilbertson, V. Ophascharoensuk, L. Truong, R. J. Johnson, and C. E. Alpers Obstructive Uropathy in Mice and Humans: Potential Role for PDGF-D in the Progression of Tubulointerstitial Injury J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2544 - 2555. [Abstract] [Full Text] [PDF]

				M. Awazu, S. Omori, K. Ishikura, M. Hida, and H. Fujita The Lack of Cyclin Kinase Inhibitor p27Kip1 Ameliorates Progression of Diabetic Nephropathy J. Am. Soc. Nephrol., March 1, 2003; 14(3): 699 - 708. [Abstract] [Full Text] [PDF]

				G. Wolf and S. J. Shankland p27Kip1: The "Rosebud" of Diabetic Nephropathy? J. Am. Soc. Nephrol., March 1, 2003; 14(3): 819 - 822. [Full Text] [PDF]

				G. Wolf Molecular Mechanisms of Diabetic Mesangial Cell Hypertrophy: A Proliferation of Novel Factors J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2611 - 2613. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673